Celldex Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Celldex Therapeutics, Inc. (CLDX) reported Capital Expenditures Incurred but Not yet Paid of $75.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2017-11-07
- Celldex Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2017-09-30 was -$12.00K.
- Celldex Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2017-06-30 was -$283.00K.
- Celldex Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2017-03-31 was $370.00K, a 33.09% increase year-over-year.
- Celldex Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2016-09-30 was -$43.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month |
|---|---|---|---|
| 2017-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$295.00K derived: sum of 2 quarters · filed 2017-11-07 | $75.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $87.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $370.00K 10-Q · filed 2017-05-09 | ||
| 2016-09-30 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$213.00K derived: sum of 2 quarters · filed 2017-11-07 | $65.00K 10-Q · filed 2017-11-07 |
| 2016-06-30 | -$170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $108.00K 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $278.00K 10-Q · filed 2017-05-09 | ||
| 2015-09-30 | -$465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$801.00K derived: sum of 2 quarters · filed 2016-11-07 | $38.00K 10-Q · filed 2016-11-07 |
| 2015-06-30 | -$336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $503.00K 10-Q · filed 2016-08-08 | |
| 2015-03-31 | $839.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |